SBIR/STTR Research Award

Development of High-expressing Ion Channels for Research and Therapeutic Applicat

Award identifier 4f5feb11b78b8bbaae1dc701d41d5344345abae0d625d9ff2d8af1561fecc6c5Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$471,745

Program and phase

SBIR · Phase I

Award year

2014

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
INTEGRAL MOLECULAR INC
Proposal award date
2014-09-05
Contract end date
2016-05-31
UEI
DY9KSWE8EJB8
Solicitation number
PA11-335
Topic code
300

Research abstract

DESCRIPTION provided by applicant Ion channels such as Kv and Nav are involved in a number of human disorders including autoimmunity and pain that affect andgt million Americans annually and are poorly treated However ion channels are typically exceptionally difficult to express at high levels due to their structural complexity and toxicity s a result many research and therapeutic applications for these targets have been very limited where high levels of membrane protein are required For example for human voltage gated potassium Kv and sodium Nav ion channels there are no solved crystal structures and no therapeutic monoclonal antibodies MAbs approved by the FDA or even in clinical trials despite the high level of pharmaceutical interest in such MAbs as therapeutics These applications all typically require high levels of protein expression and the expression of most ion channels is usually orders of magnitude below what is required for success Here we propose to develop a versatile platform for expressing high levels of conformational ion channel proteins Our use of this platform within the scope of this proposal will be for isolating unique MAbs against Kv and Nav We expect that this platform will be extensible to other ion channels and will also have utility for structural research high throughput screening and as biomedical research reagents PUBLIC HEALTH RELEVANCE This proposal will contribute to human health and the cure of human disease through the development of a platform for high expressing ion channels that can be used for research and therapeutic applications Our own use of this platform within the scope of this proposal will be for isolating unique MAbs that can be developed into human therapeutics to treat pain and auto immune disorders conditions that affect andgt million Americans each year and that currently have poor treatments We expect that this platform will also have utility for structural research high throughput screening and as biomedical research reagents

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

48 SBIR/STTR records share this UEI (2002–2025). Reported award amounts total $32,839,788. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.